ArticleJournal of enzyme inhibition and medicinal chemistry2022

Repurposing FDA-approved sulphonamide carbonic anhydrase inhibitors for treatment of

Nader S Abutaleb et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.